Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Bioasis Technologies Inc. (BIOAF) had Consolidated Net Income/Loss of $-0.73M for the most recently reported fiscal quarter, ending 2022-11-30.
| Income Statement Financials | |
$0.11M |
|
$-0.73M |
|
-- |
|
$0.11M |
|
$0.63M |
|
$-0.52M |
|
$-0.21M |
|
$-0.73M |
|
$-0.73M |
|
$-0.73M |
|
$-0.73M |
|
|
Consolidated Net Income/Loss |
$-0.73M |
$-0.73M |
|
$-0.52M |
|
$-0.49M |
|
78.21M |
|
78.21M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.28M |
|
$0.00M |
|
$1.02M |
|
$1.31M |
|
$2.67M |
|
$0.58M |
|
$0.64M |
|
$3.31M |
|
$-2.00M |
|
$-3.03M |
|
$-2.00M |
|
79.41M |
|
| Cash Flow Statement Financials | |
$-0.93M |
|
-- |
|
$-0.28M |
|
$1.28M |
|
$0.12M |
|
$-1.17M |
|
$0.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.11 |
|
-- |
|
-- |
|
-0.41 |
|
-0.84 |
|
100.00% |
|
-469.24% |
|
-469.24% |
|
-- |
|
-661.81% |
|
-661.81% |
|
$-0.93M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
10.75 |
|
8.37 |
|
36.55% |
|
24.18% |
|
-55.91% |
|
51.37% |
|
$-0.03 |
|
$-0.01 |
|
$-0.01 |
|